Connect with us

CBD Stocks

Can Isodiol International Inc (CNSX:ISOL)(OTCMKTS:ISOLF) Break Out From Here?



Isodiol International

Investors have jumped on Isodiol International Inc (CNSX:ISOL)(OTCMKTS:ISOLF) stock this month. The stock gained 62% on January 21, marking its best day so far in 2020. The stock has already gained 106% year-to-date. But do not think even for a minute that investors have warmed up to Isodiol stock for nothing. This is a stock with tremendous potential and at this point, the stock is just showing early signs of what is going to be a big breakout.

In case you are wondering why investors have started jostling for a piece of Isodiol early on in the year, this report answers that question and more. But before we delve into the details, it is important to first understand the company we’re discussing here.

About Isodiol International

Isodiol International is a Canadian company that has specialized in the making of pharmaceutical and consumer products derived from hemp. It makes CBD products derived from hemp grown and processed in the United States. Though Isodiol’s operations are currently concentrated in North America, the company has big expansion dreams. It has set its sights on expanding into Latin America, Asia, and Europe.

What exactly is drawing investors to Isodiol stock and why does it stand out as a good pick in the hemp/cannabis stock universe in 2020? The simple answer is that investors are beginning to realize Isodiol’s bright prospects as a CBD products company.

Isodiol bidding for $23.6 billion revenue opportunity

The market for Isodiol products is expanding rapidly, indicating a bright outlook for Isodiol whose CBD products serve both pharmaceutical and consumer goods market segments. The global market for CBD products, comprising both cannabis and hemp CBD products sale, was valued at $4.9 billion in 2018. The market is now on track to hit $23.6 billion by 2025.

Isodiol brings its Iso-Sport brand to respected nutritional products retailer The Vitamin Shoppe

In October, Isodiol partnered with respected American nutritional supplements retailer The Vitamin Shoppe to sell its Iso-Sport products at hundreds of its stores. Iso-Sport is a sports performance product made from hemp-based CBD.

Vitamin Shoppe has emerged as a one-stop-shop for CBD hemp extract products. Therefore, Isodiol expects significant market exposure for its Iso-Sport brand by bringing it to The Vitamin Shoppe stores. The Vitamin Shoppe will stock Iso-Sport at 390 of its retail locations. The sale of Iso-Sport at Vitamin Shoppe locations began in October.

Isodiol International strengthens its leadership team with a former Bank of America and McDonald’s executive

As a company with a long-term outlook and a strong commitment to creating superior shareholder value, Isodiol has made building a strong leadership team a priority. In October, the company hired former Bank of America (NYSE:BAC) and McDonald’s Corp (NYSE:MCD) executive Andrew Alvis as its president.

At Bank of America, Alvis oversaw aspects of the giant lender’s operations related to acquisitions and mortgage servicing. At McDonald’s, Alvis served as chief of operations for the McDonald’s Channel. He oversaw the coffee retailer’s operations across Europe and led restructuring efforts that increased sales by 50% and resulted in profits. Alvis also held a senior role at Toyota’s financial services unit.

Isodiol will leverage Alvis’s experience and global network to speed up its global expansion.

ISOLF boasts improving financials and strong balance sheet

The efforts by Isodiol to boost sales such as through the retail arrangement with The Vitamin Shoppe and the hiring of highly experienced executives build on a strong financial position. Isodiol finished its 2020 fiscal first quarter, the period ending June 2019, with $4.8 million in working capital comprising $3.0 million cash. That goes on to show that Isodiol has the financial capability to continue executing on its development plans.

In the fiscal first quarter, Isodiol primarily set out to reduce its operating expenses with a focus on moving toward profitability. And that was a tremendous success. The company was able to lower its operating expenses $13 million sequentially and $3.0 million year-over-year, thereby coming very close to profitability in the fiscal first quarter. It posted a net loss of $2.8 million in the fiscal first quarter, compared to a net loss of $96 million in the fiscal fourth quarter.

Bottom line

Investors will agree that 2019 was a disastrous year for the cannabis/hemp sector. But the year also offered a vital investing lesson: great stocks win. Isodiol International is showing great potential in 2020.

We will be updating our subscribers as soon as we know more. For the latest updates on Isodiol International, sign up below!

Disclosure: We have no position in Isodiol International and have not been compensated for this article.

Continue Reading
Click to comment

CBD Stocks

New Age Beverage (NASDAQ:NBEV) Solid Fundamentals Amidst Price Slump



New Age Beverage

New Age Beverage (NASDAQ:NBEV) has taken a significant beating since the start of the year. A 60% plus slide attests to a stock under immense pressure. Amidst the underperformance in the stock market, the company has continued to do exceedingly well when it comes to core business execution and operation efficiency.

New Age Beverage Catalysts And Price Analysis

 Triple-digit revenue growth is one of the developments that continues to affirm the company’s long-term prospects. The company also remains well-positioned to generate bottom-line growth backed by robust retail channels in the U.S as well as expansion in Asia. Integration of Morinda operations in China is another development likely to continue strengthening the company’s bottom line going forward.

 A spike in implied volatility in the options market is the latest development that signals a potential turnaround in the direction of trade. Huge implied volatility indicates that trade is developing. What is clear is that the stock has taken a significant hit and may be due for a correction higher, given the improving fundamentals.

Increased activity around the $2.50 Put options could signal a potential change in the direction of trade. After the recent slide lower, the stock needs to rise and find support above the $2.40 resistance level. A rally past the $2.40 level should reaffirm New Age Beverages bounce back prospects.

Above the crucial resistance level, the stock should be on its way to the…

Continue Reading

CBD Stocks

Charlotte’s Web Stock (TSE:CWEB) (OTCMKTS:CWBHF) Poised For Breakout And Here’s Why



Charlotte's Web Stock

Charlotte’s Web Stock (TSE:CWEB) (OTCMKTS:CWBHF) is currently at one of its lowest price levels in about five months. That is the result of a selloff that kicked off toward late September after the stock reached one of its highest watermarks at $23 in August.

You cannot rule out profit-taking as having contributed to the decline that has brought the stock to its current lows considering the stock pulled up from one of its lowest levels this year in July before the August breakout. A repeat of the August bull run that powered CWBHF to one of its highest price levels this year seems to be in the offing.

Firstly, after a string of declines for much of last week and early this week, CWBHF has begun showing signs of a comeback. The stock closed the last session (November 5), up. Now the stock has found immediate support at $10.9 from where it looks set for a powerful breakout as happened in March, June, and July.

In March, for instance, CWBHF bolted from a low of $13 on March 8 to reach its one-year peak of $25 in a space of fewer than 30 days on April 4. Profit-taking kicked off after that and the stock fell to around $10 in mid-June, from where it began rising again, topping $18.5 in early July. Investors again took profit and toward late July the stock was back down at around $13.5.…

Continue Reading

CBD Stocks

CV Sciences, Inc. (OTCMKTS:CVSI): You Don’t Want To Miss This Bounce Back




CV Sciences, Inc. (OTCMKTS:CVSI) is currently trading at one of its lowest price points in about a year. The decline that has taken the stock to its current lows began unfolding in mid-September.

By late September, CVSI had lost so much ground that the stock was trading below $1.60. However, it again began moving up and in early October the stock had climbed back up enough to flirt with $2.60. From that level, CVSI retreated and by mid-October it was doing rounds at about $1.85. The stock began climbing back up again and toward late October it was trading well above $2. But in late October until now it has begun pulling back again, closing down in three of the last five trading sessions.

Looking at the charts, you cannot dispute that CVSI has demonstrated a pattern that investors can take advantage of to profit from the stock in short-terms. After rallying, CVSI tends to pull back, thereby allowing investors who may have missed its previous bull run to get on board before it begins another flight. Therefore, you shouldn’t be surprised if CVSI sharply reverses course and begins trending up from current levels.


CVSI is a hemp CBD company that makes products for both consumer and therapeutics markets. The company operates production facilities that follow good manufacturing practices. Its PlusCBD Oil product has been noted as the top-selling hemp CBD brand.

Continue Reading

MJ Stocks